首页> 美国卫生研究院文献>Breast Cancer Research : BCR >Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?

【2h】

Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?

机译：原发性乳腺癌的激素受体谱与转移性骨病之间的不一致：是否应将骨髓活检视为一种护理标准？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Breast Cancer Research : BCR
作者
E Amir; R Broom; O Freedman; WS Ooi; S Done; D Gianfelice; D Barth; H Kahn; M Clemons;
展开▼
作者单位

展开▼
年(卷),期 2009(11),Suppl 1
年度 2009
页码 P27
总页数 20
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care? [J] . E Amir, R Broom, O Freedman, Breast Cancer Research . 2009,第Suppla1期

机译：原发性乳腺癌激素受体谱与转移性骨病之间的不一致：是否应将骨髓活检视为一种护理标准？
2. Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies. [J] . Amir E, Ooi WS, Simmons C, Clinical oncology . 2009,第10期

机译：原发性和转移性乳腺癌中受体状态之间的不一致：对骨骼和骨髓活检组织的探索性研究。
3. Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemo [J] . Vredenburgh JJ, Coniglio D, Broadwater G, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2006,第2期

机译：与高剂量标准剂量化疗相比，高剂量联合烷基化剂与骨髓移植的合并可显着改善激素不敏感的转移性乳腺癌在完全缓解后的无病生存率
4. Minimal Residual Disease in Bone Marrow and Peripheral Blood of Patients with Metastatic Breast Cancer [C] . Joachim Bischoff, Wolfgang Janni, Michael Dahm, International Meeting on Molecular Staging on Cancer . 2003

机译：转移性乳腺癌患者骨髓和外周血中的最小残留疾病
5. Regulation of Breast Cancer Cells' Bone-metastatic Potential by Mechanically Stimulated Osteocytes [D] . Ma, Yu-Heng Vivian. 2019

机译：机械刺激的骨细胞对乳腺癌细胞骨转移潜能的调节
6. A Case of Disease Improvement after Treatment with Everolimus plus Exemestane in a Patient with Hormone Receptor-Positive Metastatic Breast Cancer with Bone Metastases [O] . J. Thaddeus Beck, Ryan Mantooth 2015

机译：依维莫司联合依西美坦治疗激素受体阳性转移性骨转移乳腺癌患者病情好转一例
7. Consolidation with High-Dose Combination Alkylating Agents with Bone Marrow Transplantation Significantly Improves Disease-Free Survival in Hormone-Insensitive Metastatic Breast Cancer in Complete Remission Compared with Intensive Standard-Dose Chemotherapy Alone [O] . Vredenburgh James J., Coniglio David, Broadwater Gloria, 2006

机译：与单独使用强剂量标准化疗相比，高剂量组合烷基化剂与骨髓移植的合并可显着提高激素敏感性不敏感转移性乳腺癌完全缓解后的无病生存率。

Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?

著录项

相似文献

相关主题

期刊订阅